Merit Medical Systems Inc (MMSI) Actualités

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

2024 preliminary unaudited revenue in the range of approximately $1.355 billion - $1.357 billion, up...

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY...

Form 8-K - Current report

Merit Medical Announces Resignation of President, Joseph Wright

SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or...

Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients

SOUTH JORDAN, Utah, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities